CRISPR Therapeutics AG (CRSP)
55.08
+2.70
(+5.15%)
USD |
NASDAQ |
May 06, 16:00
54.76
-0.32
(-0.58%)
After-Hours: 04:25
CRISPR Therapeutics Market Cap : 5.312B for May 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals, Inc. | 108.54B |
| Beam Therapeutics, Inc. | 3.294B |
| Novartis AG | 283.08B |
| EvoNext Holdings SA | 8.149M |
| Kuros Biosciences Ltd. | 987.32M |
Market Cap Related Metrics
| PS Ratio | 1240.73 |
| PEG Ratio | -0.2361 |
| Price to Book Value | 2.928 |
| Price | 55.08 |
| Earnings Yield | -11.28% |
| PEGY Ratio | -0.2361 |